Creative and resilient, the Life Sciences sector continues to buck the trend by delivering commercially viable innovation and improved patient outcomes.

Governments worldwide are seeking to invest in early stage companies, whilst global pharmaceutical companies are committed to long-term development programmes. As a consequence, the market is alive with M&A and collaboration activity.

Geldards has a strong track record in advising on corporate deals in the sector and a particular expertise in medical technology, know-how licensing, patent and trade mark dispute resolution. Our Life Science clients include universities, medical teaching hospitals, privately owned and publicly listed life science and bioscience businesses and medical product retailers.

Whether you are a large multinational, a small start up or spin-out company, or serving the public sector, our Life Sciences team can help guide you in a highly practical and commercial way through the many legal issues facing your business today and in the future.

We can help you with:


Share this page


RELATED

News

Geldards Chairman Appointed Interim Chair At D2N2
18/06/2020
Geldards Chairman David Williams has been appointed Interim Chair of D2N2 LEP with immediate effect.The change in role follows the appointment of current Chair Elizabeth Fagan as the interim Marketing Strategy Director for the newly formed NHS Track and Trace.
more...

Blogs

Chairman's Blog - A Golf Instructor Saved My Life Tonight!
04/02/2016
Chairman, David Williams, considers life as outcomes – those that we want and those that we don’t want.
more...

MAIN CONTACTS

PARTNER

Andrew Evans

ANDREW EVANS

Partner, Cardiff

+44 (0)29 2039 1761
email
more...

PARTNER

Debra Martin

DEBRA MARTIN

Partner, Derby

+44 (0)1332 378 355
email
more...